Graypoint LLC’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.11M Buy
9,120
+32
+0.4% +$24.9K 0.4% 48
2025
Q1
$7.51M Buy
9,088
+388
+4% +$320K 0.47% 41
2024
Q4
$6.72M Buy
8,700
+381
+5% +$294K 0.41% 46
2024
Q3
$7.37M Buy
8,319
+386
+5% +$342K 0.47% 42
2024
Q2
$7.18M Buy
7,933
+271
+4% +$245K 0.5% 41
2024
Q1
$5.96M Buy
7,662
+258
+3% +$201K 0.43% 50
2023
Q4
$4.32M Buy
7,404
+916
+14% +$534K 0.35% 64
2023
Q3
$3.49M Buy
6,488
+723
+13% +$388K 0.33% 73
2023
Q2
$2.7M Buy
5,765
+834
+17% +$391K 0.27% 74
2023
Q1
$1.69M Buy
4,931
+1,278
+35% +$439K 0.18% 94
2022
Q4
$1.34M Buy
3,653
+261
+8% +$95.5K 0.16% 104
2022
Q3
$1.1M Buy
3,392
+667
+24% +$216K 0.14% 112
2022
Q2
$883K Buy
2,725
+443
+19% +$144K 0.11% 130
2022
Q1
$654K Buy
2,282
+123
+6% +$35.3K 0.06% 173
2021
Q4
$596K Buy
2,159
+281
+15% +$77.6K 0.06% 174
2021
Q3
$434K Sell
1,878
-61
-3% -$14.1K 0.05% 179
2021
Q2
$445K Buy
1,939
+385
+25% +$88.4K 0.06% 170
2021
Q1
$290K Buy
+1,554
New +$290K 0.04% 194